Live tape
Top 8, mentions 7d6,143NVDA1,010 mentions▲ +0.09NKE1,001 mentions+0.01LULU955 mentions▲ +0.03GOOGL948 mentions▲ +0.04TSLA844 mentions▲ +0.06META481 mentions▲ +0.04MSFT458 mentions▲ +0.07SNDK446 mentions▲ +0.09

Equity · Healthcare

ASND

Ascendis Pharma A/S · NasdaqGS

$270.71 −0.11% 1D Finazon · prior-day close · Sep 4, 2026
Price · Chart
Our own end-of-day closes 60 sessions
$280 $200 11 Jun 4 Sep

The line runs $215 on 11 June through $270.71 on 4 September, on a scale from $200 to $280. Days the market did not trade hold the previous close, flat.

The chart above plots the price of ASND over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $215 on 11 June 2026 through $270.71 on 4 September 2026.

52-week range $189.56 – $277
Avg volume 73.8K

Finazon · prior-day close · as of Sep 8, 2026

ASND insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Sep 2026
Open-market buys 1
Open-market sells 1
Net bought $430K
Non-trade filings 0
Date Insider Type Shares Value
02 Sep 2026 HOLTUG LARS Director Sell 236 $62K
14 Aug 2026 BIENAIME JEAN JACQUES Director Buy 2,000 $493K

ASND institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a ASND position for the quarter ended 30 Jun 2026 — a combined $248.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments New position 305,803 $81.6M
Millennium Management New position 266,708 $71.1M
Citadel Advisors New position 137,889 $36.8M
Renaissance Technologies New position 119,699 $31.9M
Balyasny Asset Management New position 31,023 $8.3M
D. E. Shaw & Co. New position 30,883 $8.2M
Marshall Wace New position 22,503 $6.0M
Tudor Investment Corp New position 16,625 $4.4M

Source: SEC EDGAR 13F filings

ASND fails-to-deliver

SEC CNS data

On 12 Aug 2026, 3 shares of ASND failed to deliver (about $764).

Settlement date Shares failed Notional % of shares out
12 Aug 2026 3 $764 <0.001%

Source: SEC fails-to-deliver (CNS) data